Filter
379
Filtered Results: 379
Text search:
Food
and
Drug
Administration
(FDA)
Featured
Recommendations
43
New Publications
84
Language
Document type
No document type
198
Guidelines
86
Studies & Reports
52
Manuals
16
Fact sheets
12
Strategic & Response Plan
6
Situation Updates
3
Training Material
2
Resource Platforms
2
Brochures
1
Infographics
1
Countries / Regions
India
14
Ghana
11
Myanmar / Burma
11
Philippines
9
USA
7
Russia
7
Colombia
6
Nigeria
6
Global
6
Latin America and the Carribbean
6
South Africa
6
Western and Central Europe
5
Uganda
5
Nepal
4
Congo, Democratic Republic of
4
Ethiopia
4
South Sudan
4
Thailand
3
Kenya
3
Germany
3
South–East Asia Region
3
Indonesia
3
Rwanda
2
Syria
2
Peru
2
Africa
2
Tanzania
2
West and Central Africa
2
Middle East and North Africa
2
Eastern Europe and Central Asia
2
Paraguay
2
Argentina
2
Bangladesh
2
Brazil
2
Namibia
2
Sudan
2
Yemen
2
Angola
2
Sierra Leone
1
Chile
1
Singapore
1
Senegal
1
Malawi
1
Zimbabwe
1
Mozambique
1
Haiti
1
Cambodia
1
Asia
1
Guinea-Bissau
1
Venezuela
1
Jordan
1
Eastern Europe
1
Botswana
1
Iraq
1
Liberia
1
Authors & Publishers
Publication Years
Category
Guidelines
37
COVID-19
28
Drugs & Medical Equipment
20
Policies & Guidelines HIV & TB
18
Policies
13
HIV & STI
13
TB
11
Hepatitis
10
Studies & Reports
8
Capacity Building
7
Reproductive Health
6
Pediatrics
5
Women & Child Health
5
Diabetes
4
MPOX - Monkeypox
4
Medical Devices & Equipment
4
Gynaecology & Obstetrics
4
Malaria
4
Pharmacy & Technologies
4
Vector Control
3
Virology
3
Community Health
3
Non-communicable Diseases
3
Laboratory Quality Assurance
3
Communicable Diseases
2
Medicines Donations
2
Clinical Training
2
Family Planning
2
Bacteriology
2
Cancer Treatment & Resources
2
Countries
2
Chagas
2
Communicable Diseases
2
Age & Elderly
2
Neonatal Care
2
Disease Prevention & Control
2
Dental & Eye Care
1
Paediatrics
1
Pharmacy & Technology
1
Under-5 nutrition
1
Buruli Ulcer
1
Disaster Preparedness
1
Cancer
1
Cervical Cancer
1
Infection Control & Prevention (IPC)
1
Yersinia pestis (Plague)
1
Vaccine-preventable Diseases
1
Pharmaceutical Assessments
1
Cardiovascular Diseases
1
Hemorrhagic Fever
1
Diarrhoeal Disease/Cholera
1
Clinical Guidelines
1
Information, Education and Communication (IEC)
1
Humanitarian Crisis
1
Statistics
1
Diarrhoea
1
Immunization
1
General Guidelines
1
NTDs & Others
1
Maternal Health
1
Neurology & Psychology
1
Parasitology
1
Key Resources
1
Global Health
1
Toolboxes
Country specific documents
18
Children/Adolescents Mental Disorders
17
IACAPAP International Association for Child and Adolescent Psychiatry and Allied Professions
15
Drug resistant TB
11
Clinical Guidelines
10
Diagnostics & Laboratory Guidance
10
PPE Personel Protective Equipment
8
Studies
7
HIV testing & services
6
Clinical Aspects, Treatment & Prevention
6
Adults
6
Detection & Diagnosis
6
Antiretroviral Treatment ART
6
Country specific
5
Infection Control General
5
Essential Medicines
5
Substance Use Disorders & Addiction
5
Testing Guidelines
5
Treatment & Prevention
4
Children & Adolescents
4
Research
4
For Health Worker
4
Pharmacy Practice
4
Rational use of Medicine
4
Pharmacovigilance
4
others
4
Alzheimer's Disease & Dementia
4
Bipolar Affective Disorders
4
TB & Prisoners
4
Depression
4
Hepatitis
3
General
3
Essential Medicines & Medical Devices
3
Hospital Readiness/Essential Health Services
3
Communication Material
3
Biontech/Pfizer Comirnaty
3
Prices and Patents
3
Quality Assurance
3
Mental Disorders
3
Antimicrobial Resistance (AMR)
3
MPOX - Monkeypox
3
Overview, Studies & Reports
3
Neurological Disorders
3
Research & Access
3
Assessment
3
Preparedness & Prevention
3
ART Drug Resistance
2
Prevention & Control
2
Clinical Guidelines
2
Treatment Guidelines HIV
2
Public Health
2
TB & Other Vulnerable Populations
2
Drug resistance
2
International
2
Treatment Guidelines
2
Supporting tools
2
Oxygen Therapy
2
Blood Supply
2
TB/HIV
2
Preparedness, Response & Risk Communication
2
Logistics & Supply
2
Fair Allocation & Ethical Aspects
2
SARS-CoV-2 Variants
2
Vaccine Hesitancy & Myths
2
Falsified & Substandard
2
Medicine Donations
2
Supply Chain & Store Management
2
Reports & Studies
2
Chagas
2
Clinical Aspects & Diagnostics
2
Studies & Reports
2
Clinical Aspects & Diagnosis
2
Women
2
Clinical Guidelines
2
Technical Information
2
Training
2
Technical Information
2
Roadmaps, Action Plans & Policies
2
TB/HIV Coinfection
2
Tobacco
2
Anxiety Disorders
2
Lobby and Advocacy
2
Plague Prevention & Control
2
Treatment Guidelines
1
Policies & Strategies
1
Clinical Guidelines
1
Male Circumcision
1
General Reports
1
TB & Drug Abuse
1
Agriculture & Veterinary
1
Posttraumatic stress disorder Adults
1
Faith-based Organizations
1
Surveillance
1
Background PTSD in children
1
Chemical Attacks
1
Preparedness, Response & Risk Communication
1
Opportunistic Infections
1
Policies & Programmes
1
Plague
1
Schizophrenia
1
Context, Facts & Travel Advice
1
Infection Control
1
Opoids
1
Curricula & Core Competencies
1
Drug resistance
1
General Studies & Reports
1
TB
1
Prophylaxis
1
Preparedness, Response & Risk Communication
1
Children
1
Training Supporting Material mhGAP
1
Clinical aspects
1
Attention deficit hyperactivity disorder (ADHD)
1
Laboratory & Sampling
1
Climate & Health
1
Laboratory
1
Prevention & Preparedness
1
Universal Health Coverage UHC and 90-90-90 Strategy
1
Research & Development
1
Livestock production
1
Surveillance & Contact tracing
1
Faith-based Organizations
1
Clinical Guidelines
1
Scientific & Research Studies
1
Educational Settings
1
Workplace
1
Paediatrics
1
Physical Distancing
1
Medical & Community Masks
1
Access & Strategy
1
Gambling
1
Genomic sequencing
1
COVAX Initiative
1
Moderna
1
Johnson & Johnson
1
Research & Pipeline
1
Hygiene
1
Food environments
1
Overview & reports
1
Essential Medicines & Devices Lists
1
Pharmacy Management
1
Pharmaceutical Assessments
1
Resuscitation
1
One Health
1
Agriculture incl. animal husbandry
1
Waste Managment
1
Environment
1
Zoonoses
1
Nuclear & Chemical Hazards
1
MPOX - Monkeypox
1
MPOX -Monkeybox Prevention & Control
1
NTDs
1
Information & Education Material (IEC)
1
Studies & Reports
1
Studies & Reports
1
Studies & Reports
1
Awareness
1
Prevention & Strategies
1
Studies & Reports
1
Prevention & Strategies
1
Clinical Aspects & Diagnosis
1
Global Overview
1
Postexposure Prophylaxis (PEP), Pre-Exposure Prophylaxis (PrEP)
1
Co-Morbidities (except TB)
1
Ghana
1
General
1
General Aspects
1
Regional Reports & Guidelines, others
1
Human Rights & the Right to Health
1
Asia
1
Diarrhoea
1
Prevention of mother-to-child transmission (PMTCT)
1
Germany
1
Situation Reports & Updates
1
Technical Information
1
Vision Loss & Blindness
1
Situation Reports
1
Zika Prevention & Control
1
Clinical Guidelines
1
Others
1
AmR (Region of Americas)
1
TB
1
Reports & Studies Children HIV
1
Preparedness & Prevention
1
IEC Material Neurological Disorders
1
Eastern Europe & Central Asia
1
Laboratory & Diagnostics
1
AMR
1
Reports & Studies
1
Global Health Ethics
1
1.HIV infections – drug therapy. 2.Anti-HIV agents – adverse effects. 3.Anti-retroviral agents. 4.Benzoxazines – adverse effects. 5.Pregnancy. 6.Disease transmission, Vertical - prevention and control. 7.Treatment outcome. I.World Health Organization
There is an urgent need for safer, simpler, more efficacious and accessible treatment regimens for all forms of TB. The development of Target Product Profiles for TB treatment regimens (referred to as Target Regimen Profiles or TRPs) seeks to guide the drug development process towards important regi...
This Indicator-Based Pharmacovigilance Assessment Tool (IPAT) was developed as a comprehensive performance metric for pharmacovigilance and medicine safety systems.
The mandate of the National Tuberculosis Control Programme is to provide leadership and stewardship to accelerate intense and coordinated efforts to reduce the adult TB burden of 290 per 100,000 population recently established in the 2013 National TB Prevalence Survey. Other key challenges are low T...
Situational Analysis: 13-23 October 2014
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report prepared using the WHO/SEARO workbook tool for undertaking a situational analysis of medicines in health care delivery in low and middle income countries
Report: A survey conducted among the 27 high MDR-TB burden countries.
March – July 2015
Stop TB Partnership in collaboration with Medecins Sans Frontieres (MSF).
Accessed November 2017.
MMWR: Recommendations and Reports / Vol. 62 / No. 9
Morbidity and Mortality Weekly Report
October 25, 2013
Therapeutics Information and Pharmacovigilance Centre | TIPC
This report provides an update on the key facets of HIV treatment access, including the latest HIV treatment guidelines from World Health Organization (WHO), an overview on pricing for first-line, second-line, and salvage regimens, and a summary of the opportunities for – and threats to – expand...
Of the 50 antibiotics in the pipeline, 32 target WHO priority pathogens but the majority have only limited benefits when compared to existing antibiotics. Two of these are active against the multi-drug resistant Gram-negative bacteria, which are spreading rapidly and require urgent solutions.
Gr...
Cloth masks and mask sterilisation as options in case of shortage of surgical masks and respirators
recommended
This document aims to provide advice on the use of cloth face masks and sterilisation of respirators and surgical masks as an alternative in healthcare settings with suspected or confirmed COVID-19 cases if there is a shortage of specialised surgical masks and respirators.
The consolidated guidelines are complemented by an operational handbook which is designed to assist with implementation of the WHO recommendations by Member States, technical partners and others who are involved in the management of patients with DR-TB. The WHO Operational Handbook on Tuberculosis, ...
This report presents an analysis of antibacterial agents in preclinical (third annual review) and clinical (fifth annual review) development. The analysis covers traditional (direct-acting small molecules) and non-traditional antibacterial agents in development worldwide. It evaluates to what extent...
This series of supportive tools are based on the WHO Therapeutics and COVID-19: living guideline. They are intended to provide supportive information for healthcare workers who are prescribing, administering and monitoring patients receiving nirmatrelvir-ritonavir for non-severe COVID-19.
